<qa>  What is the exposure to a potent or moderate inhibitor or inducer?- Exposure to potent or moderate inhibitors or inducers of CYP3A45, Pgp MDR1 and BCRP if taken within the stated washout periods before the first dose of study treatment see Appendix B 